Respiratory Effects of Timolol

Research output: Contribution to journalLetter

59 Scopus citations

Abstract

To the Editor: The 34th most commonly prescribed medication in the United States in 1983 was an eye drop used in the management of glaucoma, timolol (Timoptic, Merck Sharp and Dohme). Beta-blocking agents given for the topical ophthalmic effects are contraindicated in patients with bronchial asthma, bronchospasm, or severe chronic obstructive pulmonary disease. The National Registry of Drug-Induced Ocular Side Effects, at the Department of Ophthalmology, Oregon Health Sciences University, has now received over 200 reports of possible major timolol-induced respiratory effects. Although the manufacturer's package insert has included asthma as a contraindication to timolol administration since 1983, physicians and.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume311
Issue number22
DOIs
StatePublished - Nov 29 1984

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this